NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.04
-0.03 (-0.49%)
Aug 25, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $75.85 million as of August 26, 2026. Its market cap has increased by 211.48% in one year.
Market Cap
75.85M
Enterprise Value
67.81M
1-Year Change
211.48%
Ranking
Category
Stock Price
$6.04
ChartMarket Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $75.85M, an increase of 312.85%. That is a compound annual growth rate of 59.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 75.85M | 56.83% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MAIA Biotechnology | 82.11M |
| Eloxx Pharmaceuticals | 80.69M |
| Telomir Pharmaceuticals | 80.47M |
| OKYO Pharma | 78.72M |
| Alterity Therapeutics | 78.58M |
| Elicio Therapeutics | 78.32M |
| Cardiff Oncology | 77.64M |
| MediciNova | 75.31M |